Gert Peters

Title: Gert Peters: Innovator in Synthetic Biology

Introduction

Gert Peters is a notable inventor based in Ghent, Belgium, recognized for his contributions to the field of synthetic biology and metabolic engineering. With a total of three patents to his name, Peters has made significant strides in the synthesis of complex biological compounds.

Latest Patents

One of Peters' latest patents focuses on the in vivo synthesis of sialylated compounds. This innovation involves engineered microorganisms capable of synthesizing sialylated compounds through an intracellular biosynthesis route. The microorganisms can dephosphorylate N-acetylglucosamine-6-phosphate to N-acetylglucosamine and further convert it to N-acetylmannosamine, eventually producing N-acetyl-neuraminate. This method allows for large-scale synthesis of sialylated compounds by culturing microorganisms in a suitable culture medium.

Another significant patent by Peters involves the production of a mixture of neutral non-fucosylated oligosaccharides. This disclosure describes a metabolically engineered cell designed to produce at least four different neutral non-fucosylated oligosaccharides. The patent also outlines a method for the production and purification of these oligosaccharides from the cultivation process.

Career Highlights

Gert Peters is currently associated with Inbiose N.V., where he continues to advance his research in synthetic biology. His work has been instrumental in developing innovative methods for the production of biologically relevant compounds.

Collaborations

Peters collaborates with talented individuals such as Joeri Beauprez and Pieter Coussement, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Gert Peters stands out as a prominent inventor in the field of synthetic biology, with a focus on the synthesis of complex compounds through innovative methodologies. His contributions are paving the way for advancements in metabolic engineering and synthetic biology.